Efficacy Study of VA106483 in Males With Nocturia.
NCT01038843
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
152
Enrollment
INDUSTRY
Sponsor class
Conditions
Nocturia
Interventions
DRUG:
VA106483
Sponsor
Vantia Ltd